MAP2K7 and neoplasm: Additionally, HBV middle surface antigen activates the Ras/MEK/ERK pathway through a protein kinase C (PKC)‐dependent mechanism, further enhancing the survival of HBV‐infected cells and contributing to tumor formation [431].